CellX Biosolutions receives CHF 150,000 from Venture Kick
The ETH spin-off CellX Biosolutions has received CHF 150,000 from Venture Kick to further develop its bacterial products for the CO2-free degradation of chemicals and to improve scaling for industrial applications.
Industrial chemical waste is a global challenge. Conventional disposal methods such as incineration lead to high costs and CO2 emissions. In addition, existing biological approaches are often limited in their scalability and efficiency, highlighting the urgent need for improved waste management solutions.
The ETH spin-off CellX Biosolutions combats chemical pollution with powerful bacterial degradation products. These enable CO2 emission-free degradation of industrial pollutants. Using a microfluidic tool, CellX identifies unique bacteria with high degradation performance that can break down harmful chemicals such as PFAS and pharmaceuticals even in remote environments. This sustainable approach offers an environmentally friendly alternative to conventional disposal methods.
CellX plans to serve a market of over USD 1 billion
The market for the treatment of hazardous chemical waste is expected to reach USD 48 billion by 2027 due to stricter environmental regulations and the growing demand for sustainable solutions. CellX Biosolutions has great potential in this area with its products for high-priority pollutants. The company already has strong customer contacts in the early stages and plans to serve a market of over USD 1 billion, including large PFAS manufacturers and pharmaceutical companies looking for environmentally friendly waste management solutions.
CellX will use the CHF 150,000 from Venture Kick to accelerate business and product development, contributing to its pre-seed round of CHF 1.2 million. This is expected to close in the first quarter of 2025.
The CellX team is made up of founder and CEO Dr. Estelle Clerc, who has a doctorate in microbiology, co-founder and COO Geoffrey Besnier, product manager Dr. Fabienne Kurt and technical manager Christian Engler. All of them bring specific expertise to the company.
"Venture Kick has enabled us to achieve important milestones: building partnerships, securing expert legal advice and gaining visibility with investors. This support has been critical to our business and product development. Since the start of the program in February 2024, we have secured USD 1.2 million in support and set CellX up for growth in the industry," emphasized CEO Estelle Clerc.
Source: www.venturekick.ch
